Home › Funds › GENEVA CAPITAL MANAGEMENT LLC › GMED
GENEVA CAPITAL MANAGEMENT LLC position in GMED
GLOBUS MED INC · Health Care
GENEVA CAPITAL MANAGEMENT LLC reported holding 1,249,396 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$93.6M, representing 2.61% of its reported portfolio and ranking #11 among its reported holdings. GENEVA CAPITAL MANAGEMENT LLC has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GENEVA CAPITAL MANAGEMENT LLC's GMED position evolved
GENEVA CAPITAL MANAGEMENT LLC first disclosed a stake in GMED in Q3 2023 at 1,422,224 shares (US$70.6M). The position peaked in Q4 2025 at 1,901,974 shares, worth US$166.1M. Across 13 filings, GENEVA CAPITAL MANAGEMENT LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,249,396 shares valued at US$93.6M — a reduction of -167,671 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.42M | $70.61M | New |
| Q4 2023 | 1.42M | $75.77M | Hold |
| Q1 2024 | 1.57M | $84.32M | Add |
| Q2 2024 | 1.58M | $108.22M | Add |
| Q3 2024 | 1.60M | $114.33M | Add |
| Q4 2024 | 1.82M | $150.19M | Add |
| Q1 2025 | 1.83M | $134.22M | Add |
| Q2 2025 | 2.08M | $122.93M | Add |
| Q3 2025 | 2.08M | $119.35M | Hold |
| Q4 2025 | 1.90M | $166.06M | Reduce |
| Q1 2026 | 1.76M | $151.73M | Reduce |
| Q2 2026 | 1.42M | $111.96M | Reduce |
| Q3 2026 | 1.25M | $93.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 35 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M sh · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M sh · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
More on GENEVA CAPITAL MANAGEMENT LLC
FAQ
How long has GENEVA CAPITAL MANAGEMENT LLC held GMED?
GENEVA CAPITAL MANAGEMENT LLC has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GENEVA CAPITAL MANAGEMENT LLC's current position in GMED?
As of Q3 2026, GENEVA CAPITAL MANAGEMENT LLC holds 1.25M shares of GMED (GLOBUS MED INC), valued at $93.58M, representing 2.61% of its reported portfolio and ranking #11.
Has GENEVA CAPITAL MANAGEMENT LLC been buying or selling GMED?
In the latest 13F filing (Q3 2026), GENEVA CAPITAL MANAGEMENT LLC reduced its position in GMED. The position peaked in Q4 2025 at 1.90M shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.